Jubilant Therapeutics India Limited - Company Profile

It is a healthcare public limited company based in Noida, Uttar Pradesh, India, established in 2019.
2019 Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Jubilant Therapeutics India Limited

Jubilant Therapeutics India Limited, a active public limited company, was established on 20 March 2019 in Noida, Uttar Pradesh, India. Engaging in oncology clinics & cancer treatment within the professional, scientific and technical sector, it holds CIN: U74994UP2019PLC114901. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹86.65 Cr and a paid-up capital of ₹86.65 Cr.

Employing 13 professional, Its leadership includes Sanjay Gupta (Director), Sridharan Rajagopal (Whole-Time Director), Shyam Pattabiraman (Director). Past directors included Rajesh Kumar Srivastava, Sanjay Gupta, Arvind Chokhany. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at 1-A Sector 16 A, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74994UP2019PLC114901

  • Registration Number

    114901

  • Incorporation Date

    20 March 2019

  • Authorized Capital

    ₹86.65 Cr

  • Paid-Up Capital

    ₹86.65 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 86.65 Cr
  • Paid Up Capital ₹ 86.65 Cr
  • Company Age 7 Year, 12 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 14.08%
  • Profit Growth **** 63.79%
  • Ebitda **** -74.76%
  • Net Worth 20.61%
  • Total Assets **** 19.94%
Company report

Jubilant Therapeutics India Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jubilant Therapeutics India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jubilant Therapeutics India Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Gupta Director 16 Jul 2021 Current
Sridharan Rajagopal Whole-Time Director 15 May 2019 Current
Shyam Pattabiraman Director 08 Sep 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Jun 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Director 01 Apr 2020 Past
Pramod Abcsdd Director 17 Sep 2019 Past
Pramod Abcsdd Additional Director 17 Jul 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jubilant Therapeutics India.

Jubilant Therapeutics India Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.08% increase. The company also saw a substantial improvement in profitability, with a 63.79% increase in profit. The company's net worth Soared by an impressive increase of 20.61%.

Jubilant Therapeutics India revenue growth over time
Jubilant Therapeutics India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.08%
*******
*******
*******
*******
Revenue from Operations
*******
 -26.34%
*******
*******
*******
*******
Total Assets
*******
 19.94%
*******
*******
*******
*******
Profit or Loss
*******
 63.79%
*******
*******
*******
*******
Net Worth
*******
 20.61%
*******
*******
*******
*******
EBITDA
*******
 -74.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jubilant Therapeutics India?

In 2024, Jubilant Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Jubilant Therapeutics India?

Jubilant Therapeutics India has a workforce of 13 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jubilant Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Therapeutics India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jubilant Therapeutics India
Recent Activity within the Organization
  • Annual General Meeting

    The activity Jubilant Therapeutics India Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Jubilant Therapeutics India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Director Appointment

    The activity Sanjay Gupta was appointed as a Director was appointed as a Director on 16 Jul 2021 & has been associated with this company since 4 years 8 months . was completed.

  • Director Appointment

    Shyam Pattabiraman was appointed as a Director was appointed as a Director on 08 Sep 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Anil Sharma was appointed as a Company Secretary was appointed as a Company Secretary on 18 Sep 2019 & has been associated with this company since 6 years 6 months . was documented.

  • Director Appointment

    Arun Kumar Sharma was appointed as a CFO was appointed as a CFO on 18 Sep 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jubilant Therapeutics India Limited?

The CIN of Jubilant Therapeutics India Limited is U74994UP2019PLC114901.

Where is Jubilant Therapeutics India Limited headquartered?

Jubilant Therapeutics India Limited is headquartered at 1-A Sector 16 A, Noida, Uttar Pradesh, 201301.

When was Jubilant Therapeutics India Limited incorporated?

Jubilant Therapeutics India Limited was incorporated on 20 March 2019.

Who are the current directors of Jubilant Therapeutics India Limited?

The current directors of Jubilant Therapeutics India Limited are

What is the primary industry of Jubilant Therapeutics India Limited?

The primary industry of Jubilant Therapeutics India Limited is Professional, Scientific And Technical.

Is Jubilant Therapeutics India Limited a listed company?

Jubilant Therapeutics India Limited is unlisted.

What is the capital structure of Jubilant Therapeutics India Limited?

The authorized capital of Jubilant Therapeutics India Limited is ₹86.65 Cr, and the paid-up capital is ₹86.65 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available